Notice of Special Interest: Kidney Precision Medicine – Technology Development and Translation

Funding Agency:
National Institutes of Health

This NOSI intends to encourage small businesses to translate kidney precision medicine discoveries and technologies.

Recent gains in access to kidney tissue and bio-samples and advances in multi-scale interrogation of human tissue and single cells have set the stage for precision medicine to be applied to kidney disease. Specifically, several cohort studies have included kidney biopsies [e.g., the Kidney Precision Medicine Project (KPMP) and the Nephrotic Syndrome Study Network (NEPTUNE)], and research consortia have advanced novel tools and technologies to interrogate bio-samples and released multi-omic data to the public. These bio-samples, technology, and data offer opportunities for technology development and translational research in the area of kidney precision medicine.

This notice applies to due dates on or after January 5, 2021 and subsequent receipt dates through September 5, 2023. 


Agency Website

Eligibility Requirements

Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity. 

Amount Description

Funding Type





Engineering and Physical Sciences
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

September 5, 2023